

Well, Now: The Full Truth About Ozempic
Jul 14, 2024
Dr. Fatima Cody Stanford discusses GLP-1 agonist drugs and their impact on obesity medicine. Topics include the mechanisms and benefits of drugs like Ozempic, challenges with compounding pharmacies, and the importance of individualized treatment plans for weight management.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 2min
Exploring the World of GLP-1 Medications
02:03 • 6min
Cautionary insights on compounding pharmacies and anticipation of expert insights
08:26 • 4min
Understanding GLP-1 Drugs in Obesity Medicine
12:22 • 19min
Implications of Recent Supreme Court Decisions and Discussion on GLP-1 Drugs
31:40 • 2min
Challenges with Medication Costs and Accessibility in Healthcare
33:32 • 14min
Respecting and Prioritizing Health in Disease Treatment
47:26 • 3min